Syntax Research, Inc. Medtronic PLC Transaction History
Syntax Research, Inc.
- $126 Billion
- Q2 2024
A detailed history of Syntax Research, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Syntax Research, Inc. holds 911 shares of MDT stock, worth $81,179. This represents 0.06% of its overall portfolio holdings.
Number of Shares
911
Previous 6,033
84.9%
Holding current value
$81,179
Previous $526 Million
86.36%
% of portfolio
0.06%
Previous 0.4%
Shares
4 transactions
Others Institutions Holding MDT
# of Institutions
2,222Shares Held
1.04BCall Options Held
7.09MPut Options Held
4.39M-
Vanguard Group Inc Valley Forge, PA127MShares$11.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$9.97 Billion0.2% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.37 Billion0.21% of portfolio
-
Capital Research Global Investors Los Angeles, CA31.7MShares$2.83 Billion0.56% of portfolio
-
Jpmorgan Chase & CO New York, NY28.6MShares$2.55 Billion0.2% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $118B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...